Monitra Healthcare, a Hyderabad-based company, has successfully raised $500,000 in pre-series A funding for its remote cardiac monitoring platform. The funding round was led by 91Ventures and Lavni Ventures, with participation from ACG World, AWE funds, and notable individuals such as Lakshmi Narayanan, Kishore Ganji, and Arvind Ramamurthy. This funding will support Monitra Healthcare’s next phase of growth, including expanding into international markets, establishing monitoring centers, and developing AI technology for early diagnosis of cardiac disorders.
Monitra Healthcare aims to address the challenges in monitoring cardiac arrhythmia by providing a convenient and high-quality diagnostic platform. Its flagship product, upBeat®, is designed to help physicians diagnose unexplained fainting and palpitations accurately. The platform utilizes an adhesive patch that transmits real-time data to the cloud, accompanied by a big data solution and comprehensive review layer to ensure accurate diagnosis.
The funding received from various investors demonstrates the trust and confidence in Monitra Healthcare’s management team and their ability to solve critical healthcare issues. The company has previously received grants from Biotechnology Ignition Grant, USISTEF, BIPP, SPARSH, and is backed by Indian Angel Network and Nomads.
Monitra Healthcare plans to expand its operations across India, enter international markets, and monitor various biomarkers related to heart health, such as brain strokes, oxygen saturation, blood pressure, and respiratory rate. The company’s vision for the next five years is to acquire and analyze biosignals from the human body to derive clinical insights and improve healthcare delivery.
This recent funding round marks an important milestone in Monitra Healthcare’s journey and highlights the growing demand for innovative solutions in cardiac monitoring. With their advanced technology and strong investor support, Monitra Healthcare is well-positioned to make a significant impact in the healthcare industry, both in India and globally.
Disclaimer: This article is generated and presented by OpenAI’s GPT-3 model, and does not reflect the opinions or views of the publishers. No copyright infringement is intended.
